Page last updated: 2024-11-03

primaquine and Leukemia, Erythroblastic, Acute

primaquine has been researched along with Leukemia, Erythroblastic, Acute in 1 studies

Primaquine: An aminoquinoline that is given by mouth to produce a radical cure and prevent relapse of vivax and ovale malarias following treatment with a blood schizontocide. It has also been used to prevent transmission of falciparum malaria by those returning to areas where there is a potential for re-introduction of malaria. Adverse effects include anemias and GI disturbances. (From Martindale, The Extra Pharmacopeia, 30th ed, p404)
primaquine : An N-substituted diamine that is pentane-1,4-diamine substituted by a 6-methoxyquinolin-8-yl group at the N(4) position. It is a drug used in the treatment of malaria and Pneumocystis pneumonia.

Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frischer, H1
Mellovitz, RL1
Ahmad, T1
Nora, MV1

Other Studies

1 other study available for primaquine and Leukemia, Erythroblastic, Acute

ArticleYear
The conversion of primaquine into primaquine-aldehyde, primaquine-alcohol, and carboxyprimaquine, a major plasma metabolite.
    The Journal of laboratory and clinical medicine, 1991, Volume: 117, Issue:6

    Topics: Alcohols; Aldehydes; Biotransformation; Blood; Bone Marrow; Bone Marrow Cells; Carmustine; Chromatog

1991